These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 10728803)

  • 1. Complications of cirrhosis III. Hepatic encephalopathy.
    Butterworth RF
    J Hepatol; 2000; 32(1 Suppl):171-80. PubMed ID: 10728803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms.
    Butterworth RF
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S11-6. PubMed ID: 15025246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy: An update of pathophysiologic mechanisms.
    Hazell AS; Butterworth RF
    Proc Soc Exp Biol Med; 1999 Nov; 222(2):99-112. PubMed ID: 10564534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy in alcoholic cirrhosis.
    Butterworth RF
    Handb Clin Neurol; 2014; 125():589-602. PubMed ID: 25307598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.
    Butterworth RF
    Metab Brain Dis; 2001 Jun; 16(1-2):55-65. PubMed ID: 11726089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.
    Butterworth RF
    Metab Brain Dis; 1998 Dec; 13(4):337-49. PubMed ID: 10206825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular aspects of hepatic encephalopathy].
    Márquez-Aguirre AL; Canales-Aguirre AA; Gómez-Pinedo U; Gálvez-Gastélum FJ
    Neurologia; 2010 May; 25(4):239-47. PubMed ID: 20609302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.
    Krieger S; Jauss M; Jansen O; Stiehl A; Sauer P; Geissler M; Theilmann L; Krieger D
    J Hepatol; 1997 Jul; 27(1):121-6. PubMed ID: 9252084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of hepatic encephalopathy: a new look at ammonia.
    Butterworth RF
    Metab Brain Dis; 2002 Dec; 17(4):221-7. PubMed ID: 12602499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities.
    Butterworth RF
    J Steroid Biochem Mol Biol; 2016 Jun; 160():94-7. PubMed ID: 26589093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.
    Gerber T; Schomerus H
    Drugs; 2000 Dec; 60(6):1353-70. PubMed ID: 11152016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic encephalopathy: from pathophysiology to treatment.
    Mas A
    Digestion; 2006; 73 Suppl 1():86-93. PubMed ID: 16498256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study.
    Zeneroli ML; Cioni G; Crisi G; Vezzelli C; Ventura E
    Magn Reson Imaging; 1991; 9(3):295-302. PubMed ID: 1881246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolism in patients with hepatic encephalopathy studied by PET and MR.
    Keiding S; Pavese N
    Arch Biochem Biophys; 2013 Aug; 536(2):131-42. PubMed ID: 23726863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current theories on the pathogenesis of hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Proc Soc Exp Biol Med; 1994 Sep; 206(4):329-44. PubMed ID: 7915420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study.
    Ni L; Qi R; Zhang LJ; Zhong J; Zheng G; Wu X; Fan X; Lu GM
    Eur J Radiol; 2014 Mar; 83(3):578-83. PubMed ID: 24299611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of manganese in the pathogenesis of portal-systemic encephalopathy.
    Layrargues GP; Rose C; Spahr L; Zayed J; Normandin L; Butterworth RF
    Metab Brain Dis; 1998 Dec; 13(4):311-7. PubMed ID: 10206823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.